StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gabelli Downgrades Teva Pharma (TEVA) to Hold Citing FY 2018 Outlook
February 9, 2018 5:32 AM
Gabelli downgraded Teva Pharma (NYSE: TEVA) from Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Teva Pharma (TEVA) PT Lowered to $23 at Goldman Sachs; Remains Bullish as Expectations Reset
February 9, 2018 8:52 AM
Teva Pharma (TEVA) PT Lowered to $16.50 at Wells Fargo
February 9, 2018 8:05 AM